Bacteriophage Market

Bacteriophage Market Outlook (2024 to 2034)

Growing demand for bacteriophages is due to their high use as a dietary supplement, which also minimizing the chances of infections caused due to food products. The global bacteriophage market size has been valued at US$ 50.3 million in 2024 and is projected to register 5.6% CAGR to reach a value of US$ 86.6 million by 2034-end.

Dietary supplements containing bacteriophages have a particular combination, which is estimated to attack specific organisms in the human gut. Moreover, phage therapeutics are utilized for the treatment and prevention of antibiotic-resistant infections, dysentery, urinary tract infections (UTIs), and other diseases. The increasing preference for advanced phage therapy research and personalized medicine is estimated to drive the bacteriophage market growth.

Growing incidence of bacterial infection because of climate change, aging population, and increasing global travel are set to lead to the growing adoption of bacteriophages. Several private and public companies are investing in the phage therapy sector, which is estimated to contribute to the expansion of the bacteriophage market size in the coming 10 years. These R&D activities are projected to assist in offering effective phage-based treatments.

• Demand for bacteriophage therapy in India is anticipated to increase at a CAGR of 8.1% and reach a value of US$ 5.9 million by the end of 2034.
• North America is projected to contribute 36.3% of the bacteriophage market share by 2034-end.
• Hospital pharmacies are approximated to account for 56.2% share of global sales of bacteriophages by 2034.

In recent years, there has been an increase in the demand for innovative products and advanced technologies around the world. In addition, rising government support along with the presence of well-established healthcare infrastructure, such as clinics, hospitals, etc. in some developed countries is forecasted to widen the application of bacteriophages in the coming 10 years. Moreover, growing awareness about the benefits associated with the use of bacteriophages is driving market growth.

Report Attributes	Details
Bacteriophage Market Size (2024E)	US$ 50.3 Million
Forecasted Market Value (2034F)	US$ 86.6 Million
Global Market Growth Rate (2024 to 2034)	5.6% CAGR
Market Share of Phage Probiotics (2024E)	69.1%
South Asia & Pacific Market Share (2034F)	21%
South Korea Market Growth (2024 to 2034)	6.2% CAGR
Key Companies Profiled	Armata Pharmaceuticals Inc. Life Extension Microgen Arthur Andrew Medical Probiotic America Designs for Health IntraLytix Inc. ADM The Biostation Biochimpharm Micreos Human Health

Why is There Steady Increase in Demand for Bacteriophages?

“Increasing Awareness about Healthy Gut Microbiome”

At present, more consumers are taking an interest in skewed products offering health benefits. Therefore, a noteworthy shift has been encountered in advanced treatments, which is generating demand for bacteriophages. In addition, rising cases of gastrointestinal owing to the hectic and changing lifestyles of more individuals are leading to the adoption of bacteriophages for preserving healthy bacteria. This helps facilitate better digestion, reduce intestinal inflammation, and regular bowel movements. Therefore, increasing preference for bacteriophages as one of the probiotic dietary supplements contributes to revenue streams.

“East Availability of Bacteriophage Products Through e-Commerce Platforms”

Bacteriophage is consumed as one of the popular probiotics under the dietary supplement category. It is easily available in medical dispensaries, pharmacies, hypermarkets, supermarkets, etc. Development and adoption of digitalization are making e-Commerce platforms popular shopping channels. Consumers are offered the convenience of selecting their preferred products through online channels.

What is Limiting Demand Growth for Bacteriophages to Some Level?

“High Prices of Bacteriophages and Availability of Other Pocket-friendly Antibiotics”

Higher prices of bacteriophage treatment are projected to adversely impact market growth. Various healthcare facilities, including small clinics & hospitals, etc. are not able to afford this treatment. In certain underdeveloped areas, a lack of treatment and facilities is forecasted to adversely impact demand for bacteriophage therapeutics.

Middle- and low-income countries are investing more in antibiotics, which are comparatively economical than bacteriophages. They ensure immediate outcomes, which is further expected to adversely impact global market growth opportunities.

Which Tactics are Expected to Benefit New Market Players?

“Growing Investments in R&D Activities for Drugs and Therapies”

Increasing R&D activities taking place in drugs and therapies against infectious diseases are forecasted to widen opportunities for new entrants. Various startups are taking an interest in drug development against certain health issues, including immunological disorders, infectious diseases, etc., which is expected to help them secure a position for themselves.

For instance :

• Microgen, in June 2020, started a Biological Research Center to study bacteriophages. Constant efforts are made in this center for improving treatment and prevent the adoption of antibiotics.

Country-wise Insights

This recently updated report by Fact.MR, a market research and competitive intelligence provider, reveals that North America is anticipated to contribute 36.3% of the global market revenue share by 2034. The growing prevalence of antibiotic resistance along with growing requirements for alternative options is leading to the rising sales of bacteriophages in the region.

Which Aspects are Positively Influencing Bacteriophage Market Trends in the United States?

“Presence of Prominent Market Players and Involvement in R&D Activities for Improving Phage Therapy”

Attribute	United States
Market Value (2024E)	US$ 15.2 Million
Growth Rate (2024 to 2034)	6.5% CAGR
Projected Value (2034F)	US$ 28.6 Million

The United States is evaluated to hold 83.7% share of the North American market by 2034-end. Various institutions in the country are investing in R&D activities for improving phage therapy. Multiple companies are treating bacterial infections in humans, animals, food safety, and agricultural use. Some of the prominent market companies operating in the United States include Adaptive Phage Therapeutics, Intralytix, AmpliPhi Biosciences, and PhagePro.

How are Suppliers of Bacteriophages Strategizing in China?

“Efforts by Market Players for Developing Innovative Bacteriophage Products”

Attribute	China
Market Value (2024E)	US$ 4.1 Million
Growth Rate (2024 to 2034)	8% CAGR
Projected Value (2034F)	US$ 8.8 Million

China is projected to account for 53.7% of the East Asian market share by the end of 2034. Various consumers in the country are open to the development of new technologies, which assist in healthier lifestyles. Therefore, constant efforts are put in by market players in innovative bacteriophage products. Furthermore, the increasing attentiveness of more consumers about their health is generating opportunities for prominent manufacturers of bacteriophages in China.

Category-wise Insights

Worldwide demand for phage probiotics is evaluated to increase at a CAGR of 5.6% and reach a value of US$ 59.9 million by the end of 2034, as mentioned in Fact.MR report. Increasing demand for this product is owing to its ability in improving gut health and promote the growth of good bacteria. Further, growing requirements for natural alternative products along with increasing awareness about bacteriophages are driving market growth opportunities.

Which Administration Route is Preferred for Bacteriophage Therapy?

“Growing Preference for Oral Bacteriophage Delivery for Convenience and Cost-effectiveness”

Attribute	Oral
Segment Value (2024E)	US$ 34.6 Million
Growth Rate (2024 to 2034)	5.7% CAGR
Projected Value (2034F)	US$ 60.2 Million

The oral route of bacteriophage administration is forecasted to contribute 69.5% share of the global market by 2034. Among various other drug-delivery routes, the oral route is estimated to attract more people due to its convenience in the delivery of various therapeutic agents. Ease of administration, cost-effectiveness, non-invasiveness, controlled delivery, etc. are prominent factors, which are contributing to the rising use of this oral administration phage. Furthermore, more healthcare professionals target orally administrated phages for offering localized treatment to a specific region.

Which Application of Bacteriophage is Generating Lucrative Opportunities for Market Players?

“Increasing Demand for Bacteriophages in Gastroenterology”

Attribute	Gastroenterology
Segment Value (2024E)	US$ 23.1 Million
Growth Rate (2024 to 2034)	6.3% CAGR
Projected Value (2034F)	US$ 42.4 Million

Gastroenterology is approximated to account for 49% of global market revenue share by 2034-end. There is an increase in the demand for bacteriophages for various applications, especially gastrointestinal symptoms and disorders. Bacteriophage therapy helps in the prevention and treatment of gastrointestinal disorders, which is set to broaden its demand across more geographies in the coming decade. In addition, the growing use of bacteriophages as dietary supplements for improving gut health is widening their demand.

Competitive Landscape

Key manufacturers of bacteriophages are concentrating on geographical expansion with constant involvement in the innovation of products matching consumer requirements. They are adopting various growth strategies to reach new heights. New product development, collaborations, strengthening supply chain systems, acquisitions, agreements, offering quality products, etc. are some prominent strategies, which are adopted by market players.

For instance :

• Carillon Miami Wellness Resort, in August 2021, entered into a partnership with The Biostation to launch novel functional medicine practices at the 70,000-square-foot wellness and spa facility of the resort.
• IntraLytix Inc. and AB Agri, in November 2021, established a partnership to explore bacteriophage use in animal feed as one of the effective alternatives to antibiotics and similar drugs.

Key players in the bacteriophage market are Armata Pharmaceuticals Inc., Life Extension, Microgen, Arthur Andrew Medical, Probiotic America, IntraLytix Inc., Designs for Health, ADM, The Biostation, Biochimpharm, and Micreos Human Health.

Segmentation of Bacteriophage Market Research

• By Product Type :

  • Phage Probiotics
  • Phage Therapeutics

• By Route of Administration :

  • Oral
  • Topical
  • Others

• By Application :

  • Gastroenterology
  • Respiratory Infections Treatment
  • Skin Infection Treatment
  • Wound Prophylaxis
  • Urological Infection Treatment

• By Distribution Channel :

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

• By Region :

  • North America
  • Europe
  • East Asia
  • Latin America
  • Middle East & Africa
  • South Asia & Oceania